$SLNX Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2014 at 12:42 PM

$SLNX Up to date company activities and other important information about $SLNX

$SLNX

DD Notes ~ http://www.ddnotesmaker.com/SLNX

##### recent news/filings ~ source: finance.yahoo.com

Thu, 19 Jun 2014 12:06:00 GMT ~ Solanbridge Group Inc Announces Telephone Conference Call with Shareholders
- HOUSTON, June 19, 2014 /PRNewswire/ -- Solanbridge Group Inc (SLNX) is pleased to announce that on Friday, June 20, 2014 at 9:00 a.m. Central time SLNX will be holding a telephone conference call with all SLNX shareholders. Charles R. Shirley, Managing Director of Solanbridge, stated, "We are pleased to be able to provide a telephone conference call with Mr. Andreas Korytowski, Director of EvoCrete® Industries GmbH of Bonbaden, Germany, and Mr. Charles Van Houten, Director of Shamrock Geoscience Pty Ltd of Vanderbijlpark, South Africa. Mr. Korytowski is the inventor and formulator of EvoCrete®, which is a new generation of German road and soil solidification technology. On May 29, 2014, SLNX signed a Letter of Intent (LOI) to merge with Shamrock Geoscience Pty Ltd, a South African construction and engineering firm. The LOI stipulates that the transaction will be an all-stock transaction where SLNX receives a 25% position in Shamrock's U.S.-based corporation and all of Shamrock's subsidiaries. The LOI further states that all common stock shares issued will be restricted common stock shares.
read full: http://finance.yahoo.com/news/solanbridge-gro...00061.html
*********************************************************

Fri, 30 May 2014 17:24:00 GMT ~ Solanbridge Group Inc Announces LOI to Merge with Shamrock Geoscience Pty Ltd.
- HOUSTON, May 30, 2014 /PRNewswire/ -- Solanbridge Group Inc (SLNX) is pleased to announce that on May 29, 2014, SLNX signed a Letter of Intent (LOI) to merge with Shamrock Geoscience Pty Ltd., a South African construction and engineering firm. The LOI stipulates that the transaction will be an all-stock transaction where SLNX receives a 25% position in Shamrock's U.S.-based corporation and all of Shamrock's subsidiaries. The LOI further states that all common stock shares issued will be restricted common stock shares. Charles R. Shirley, Managing Director of Solanbridge, stated "We are pleased to be working with Shamrock. We feel that there are many benefits to both parties to this transaction. Shamrock has built roads and buildings, and provided engineering services in several countries throughout the world and has developed a great reputation. We look forward to their entry into the North American market, specifically the State of Texas. They will be able to provide best of class construction and engineering services to the medical marijuana market that SLNX is developing."
read full: http://finance.yahoo.com/news/solanbridge-gro...00940.html
*********************************************************

Thu, 29 May 2014 17:04:22 GMT ~ SOLANBRIDGE GROUP, INC. Financials
read full: http://finance.yahoo.com/q/is?s=slnx
*********************************************************

Thu, 15 May 2014 18:01:00 GMT ~ Solanbridge Group Inc Announces 500 Million Common Stock Share Reduction
- HOUSTON, May 15, 2014 /PRNewswire/ -- Solanbridge Group Inc (SLNX) is pleased to announce that on May 14, 2014, due to the commitment of Solanbridge to the medical marijuana industry, the Company has cancelled and retired another 500 million common stock shares of SLNX. Those shares will be returned to the Company's Treasury immediately. This is the third promised share reduction of SLNX common stock—for a total cancellation and retirement of 1.5 billion common stock shares overall. Charles R. Shirley, Chairman of the Board and Managing Director of Solanbridge, stated \"We have now cancelled 1.5 billion shares from the stock structure of Solanbridge and we thank David Green for working with us to accomplish this task.\" Mr. Green consented to the 500 common stock share reduction on May 13, 2014. A Letter of Intent (LOI) was signed on May 12, 2014, between Mr. Beaver Paul of Germain Paul and Associates, a Quebec corporation, Mr. Earle G. Hickey of First Halifax Financial Corporation, Inc., a Nova Scotia corporation and Solanbridge, to develop medical marijuana opportunities throughout all of Canada, including Nova Scotia, with the important input of Canadian First Nations.
read full: http://finance.yahoo.com/news/solanbridge-gro...00163.html
*********************************************************

Mon, 12 May 2014 12:45:00 GMT ~ Solanbridge Group Inc Announces LOI with Germain Paul and Associates and First Halifax Financial Corp
- HOUSTON, May 12, 2014 /PRNewswire/ -- Solanbridge Group Inc (SLNX) is pleased to announce a Letter of Intent (LOI) between Mr. Beaver Paul of Germain Paul and Associates, a Quebec corporation, and Mr. Earle G. Hickey of First Halifax Financial Corporation, Inc., a Nova Scotia corporation. These corporations have joined with Solanbridge to develop medical marijuana opportunities throughout all of Canada, including Nova Scotia. Charles R. Shirley, Managing Director of SLNX stated, \"We are proud to have Mr. Beaver Paul join us.
read full: http://finance.yahoo.com/news/solanbridge-gro...00112.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=SLNX&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=SLNX&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/SLNX/company-info
Ticker: $SLNX
OTC Market Place: OTC Pink Current
CIK code: 0001165006
Company name: Solanbridge Group, Inc.
Incorporated In: MD, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/SLNX/filings
Latest financials: http://www.otcmarkets.com/stock/SLNX/financials
Latest news: http://www.otcmarkets.com/stock/SLNX/news - http://finance.yahoo.com/q/h?s=SLNX+Headlines

Major holdings: http://data.cnbc.com/quotes/SLNX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=SLNX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/SLNX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=SLNX

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Solanbridge+Group%...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...oup%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0

Short Sales: http://www.otcmarkets.com/stock/SLNX/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/SLNX/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/SLNX/research
Historical Prices: http://finance.yahoo.com/q/hp?s=SLNX+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=SLNX+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=SLNX+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=SLNX+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=SLNX+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=SLNX+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=SLNX
Balance Sheet: http://finance.yahoo.com/q/bs?s=SLNX
Cash Flow: http://finance.yahoo.com/q/cf?s=SLNX+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/SLNX
Bloomberg: http://www.bloomberg.com/quote/SLNX:US
Morningstar: http://quotes.morningstar.com/stock/s?t=SLNX
Bussinessweek: http://investing.businessweek.com/research/st...icker=SLNX
Barchart: http://www.barchart.com/quotes/stocks/SLNX
OTC Short Report: http://otcshortreport.com/index.php?index=SLNX
Investopedia: http://www.investopedia.com/markets/stocks/SLNX/?wa=0

http://www.pennystocktweets.com/stocks/profile/SLNX

##### last known share structure ~ source: otcmarkets.com

Market Value: $2,845,730 a/o Jun 20, 2014
Shares Outstanding: 948,576,746 a/o May 16, 2014
Float: 375,234,746 a/o Mar 31, 2014
Authorized Shares: 5,000,000,000 a/o Mar 31, 2014
Par Value: 0.001

##### business description ~ source: otcmarkets.com

Solanbridge Group Inc. is based in Spring, Texas and is a diversified holding company looking to expand into the medical marijuana industry by developing a commercial grower?s license in the Province of Nova Scotia, Canada and developing CBD-infused products in Nevada, California, and Colorado. Solanbridge's subsidiary, David's Steak and Seafood, in Melbourne Beach, Florida, is a classic, upscale steak house, which presents polished dining in an atmosphere of timeless elegance, offering guests the finest cuts of choice USDA meats, fresh seafood and much more.Less >>

DD Notes ~ http://www.ddnotesmaker.com/SLNX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...